James L. Mohler, MD, presented “Current NCCN Recommendations for Prostate Cancer Genetic Testing” for the Grand Rounds in Urology audience in January, 2020.
How to cite: Mohler, James L. “Current NCCN Recommendations for Prostate Cancer Genetic Testing” January, 2020. Accessed Dec 2021. https://dev.grandroundsinurology.com/current-nccn-recommendations-for-prostate-cancer-genetic-testing/
Current NCCN Recommendations for Prostate Cancer Genetic Testing – Summary:
James L. Mohler, MD, discusses the rationale and development of the 2019 NCCN guideline recommendations on genetic testing for prostate cancer. He details the workflow for developing these guidelines and changes for 2019, outlines a new decision-making algorithm for how and when men should be tested, and lays out the panel’s goals and challenges for improving genetic testing.
This educational activity is based on a series of lectures on genetic testing for prostate cancer from the 2019 Philadelphia Prostate Cancer Consensus Conference. Further activities from this conference include:
Germline Predisposition for Prostate Cancer Among African American and Other Minorities: What Do We Know?
Molecular Insights into the Germline for Prostate Cancer Initiation, Progression, and Aggressiveness
Prostate Cancer Screening & Genetic Testing: The NCCN Perspective
The Expanding World of Germline Testing for Prostate Cancer: Genetic Counseling Perspective
The Expanding World of Germline Testing for Prostate Cancer: A Clinical Trials Perspective
Current Prostate Cancer Genetic Testing Capabilities and Considerations
A Urologist’s Perspective on Germline Testing
Integration of Germline Testing in Prostate Cancer Screening